000 | 01943 a2200505 4500 | ||
---|---|---|---|
005 | 20250517041958.0 | ||
264 | 0 | _c20160629 | |
008 | 201606s 0 0 eng d | ||
022 | _a1878-1705 | ||
024 | 7 |
_a10.1016/j.intimp.2015.06.032 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLi, Wei | |
245 | 0 | 0 |
_aTanshinone IIA represses inflammatory response and reduces radiculopathic pain by inhibiting IRAK-1 and NF-κB/p38/JNK signaling. _h[electronic resource] |
260 |
_bInternational immunopharmacology _cSep 2015 |
||
300 |
_a382-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAbietanes _xpharmacology |
650 | 0 | 4 |
_aAnalgesics _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacology |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCyclooxygenase 2 _xgenetics |
650 | 0 | 4 |
_aDrugs, Chinese Herbal _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-1 Receptor-Associated Kinases _xmetabolism |
650 | 0 | 4 | _aInterleukin-1beta |
650 | 0 | 4 |
_aIntervertebral Disc _xcytology |
650 | 0 | 4 |
_aIntervertebral Disc Degeneration _xdrug therapy |
650 | 0 | 4 |
_aIntervertebral Disc Displacement _xdrug therapy |
650 | 0 | 4 |
_aJNK Mitogen-Activated Protein Kinases _xmetabolism |
650 | 0 | 4 |
_aMatrix Metalloproteinase 1 _xgenetics |
650 | 0 | 4 |
_aMatrix Metalloproteinase 13 _xgenetics |
650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xgenetics |
650 | 0 | 4 |
_aPain _xdrug therapy |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xmetabolism |
700 | 1 | _aZhang, Yu | |
700 | 1 | _aXing, Cuiyan | |
700 | 1 | _aZhang, Mengyuan | |
773 | 0 |
_tInternational immunopharmacology _gvol. 28 _gno. 1 _gp. 382-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.intimp.2015.06.032 _zAvailable from publisher's website |
999 |
_c25063121 _d25063121 |